EFFECT OF IBANDRONATE ON RISKS FOR VERTEBRAL AND NONVERTEBRAL FRACTURES IN POSTMENOPAUSALOSTEOPOROSIS (A REVIEW OF CLINICAL TRIALS)
The paper presents data of a large number of clinical trials meeting the principles of evidence-based medicines, which have dealt with the evaluation of the efficacy of ibandronate in postmenopausal osteoporosis (OP). The administration of its registered formulations (150 mg weekly oral and 3 mg qua...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
IMA-PRESS LLC
2010-06-01
|
| Col·lecció: | Современная ревматология |
| Matèries: | |
| Accés en línia: | http://mrj.ima-press.net/index.php/mrj/article/view/286 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|